Jiakang Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jiakang Yang has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- Baixiang Wang
Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University Hangzhou China
5 shared publications - Qianming Chen
Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Hangzhou, China
3 shared publications - Huiming Wang
Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, China
2 shared publications Jingyi Lu
Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, China
2 shared publications- Kexin Yang
Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University Hangzhou China
2 shared publications Lixuen Siow
Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Cancer Center of Zhejiang University, Hangzhou, China
2 shared publications
Latest Publications
- 28 April 2026
- Published by Zhejiang University Press in Journal of Zhejiang University-SCIENCE B
- Vol. 27 (8) , 817-831
Role of the immune microenvironment in bone regeneration and progress in immune-modulating bone nanobiomaterials
- 28 April 2026
- Published by Zhejiang University Press in Journal of Zhejiang University-SCIENCE B
- Vol. 27 (8) , 817-831
Role of the immune microenvironment in bone regeneration and progress in immune-modulating bone nanobiomaterials
- 21 April 2026
- Published by Wiley in Clinical Implant Dentistry and Related Research
- Vol. 28 (2) , e70150
Stepwise Modified Transcrestal Sinus Floor Elevation in Sites With 3–5‐mm Residual Bone Height: A Retrospective Study
Objectives: This retrospective study compared the clinical and radiographic outcomes of a stepwise modified transcrestal sinus floor elevation (SM‐TSFE) with the lateral sinus floor elevation (LSFE) for simultaneous implant placement in sites with 3–5 mm of residual bone height (RBH). Materials and Methods: A total of 149 patients with 3–5‐mm RBH underwent simultaneous implant placement using either SM‐TSFE ( n = 69) or LSFE ( n = 80). The follow‐up period ranged from 6 months to 8 years. Evaluated clinical outcomes included implant survival rates, sinus membrane perforation, and postoperative complications. Radiographic assessments included preoperative RBH, marginal bone loss (MBL), and vertical bone height changes. Results: Cumulative implant survival rates were comparable between SM‐TSFE (91.30%) and LSFE (93.75%) groups ( p = 0.537). However, the SM‐TSFE group demonstrated a significantly lower sinus membrane perforation rate (7.24%) compared to the LSFE group (18.75%; p = 0.047). Multivariate analysis identified maxillary sinus septa as the strongest risk factor for perforation ( p = 0.002). Regarding implant failure, TiUnite surface ( p = 0.035) and membrane perforation ( p = 0.039) were significant risk factors, while higher marginal bone height (MBH) was identified as a protective factor ( p = 0.003). Both groups exhibited comparable MBL at 2 years post‐loading ( p > 0.05). Conclusion: In sites with 3–5 mm of RBH, SM‐TSFE provides implant survival rates comparable to LSFE over the observation period but offers a significant safety advantage due to a substantially lower rate of sinus membrane perforation.
- 21 April 2026
- Published by Wiley in Clinical Implant Dentistry and Related Research
- Vol. 28 (2) , e70150
Stepwise Modified Transcrestal Sinus Floor Elevation in Sites With 3–5‐mm Residual Bone Height: A Retrospective Study
Objectives: This retrospective study compared the clinical and radiographic outcomes of a stepwise modified transcrestal sinus floor elevation (SM‐TSFE) with the lateral sinus floor elevation (LSFE) for simultaneous implant placement in sites with 3–5 mm of residual bone height (RBH). Materials and Methods: A total of 149 patients with 3–5‐mm RBH underwent simultaneous implant placement using either SM‐TSFE ( n = 69) or LSFE ( n = 80). The follow‐up period ranged from 6 months to 8 years. Evaluated clinical outcomes included implant survival rates, sinus membrane perforation, and postoperative complications. Radiographic assessments included preoperative RBH, marginal bone loss (MBL), and vertical bone height changes. Results: Cumulative implant survival rates were comparable between SM‐TSFE (91.30%) and LSFE (93.75%) groups ( p = 0.537). However, the SM‐TSFE group demonstrated a significantly lower sinus membrane perforation rate (7.24%) compared to the LSFE group (18.75%; p = 0.047). Multivariate analysis identified maxillary sinus septa as the strongest risk factor for perforation ( p = 0.002). Regarding implant failure, TiUnite surface ( p = 0.035) and membrane perforation ( p = 0.039) were significant risk factors, while higher marginal bone height (MBH) was identified as a protective factor ( p = 0.003). Both groups exhibited comparable MBL at 2 years post‐loading ( p > 0.05). Conclusion: In sites with 3–5 mm of RBH, SM‐TSFE provides implant survival rates comparable to LSFE over the observation period but offers a significant safety advantage due to a substantially lower rate of sinus membrane perforation.
- 21 January 2026
- Published by Wiley in Clinical Implant Dentistry and Related Research
- Vol. 28 (1) , e70119
A Retrospective Study of Clinical Risk Factors and Patient‐Reported Outcomes of Full‐Arch Implant‐Supported Prostheses
Objectives: This study aimed to evaluate clinical outcomes, marginal bone loss (MBL) trends, risk factors, and patient‐reported outcomes (PROs) of immediate full‐arch implant restoration to guide clinical decision‐making. Materials and Methods: A retrospective analysis was conducted on 50 patients with 256 implants who underwent immediate restoration. Clinical and imaging data, implant survival rates, and mechanical complications were analyzed. MBL was measured at five time points using cone beam computed tomography (CBCT): T0 (immediately post‐implantation), T1 (6 months), T2 (1 year), T3 (2 years), and T4 (3–5 years). PROs were assessed using the Oral Health Impact Profile‐14 (OHIP‐14) and the European Five‐Dimensional Health Inventory‐5 L (EQ‐5D‐5L). Results: The implant survival rate was 98%, with an average follow‐up of 42 ± 16.36 months. Mechanical complications occurred in 46% of cases. MBL was most rapid between T0 and T2 and slowed from T2 to T4. Significant risk factors for increased MBL included smoking, maxillary implants, female gender, and advanced age. Furthermore, 30° angled multi‐unit abutments on posterior implants were associated with greater MBL compared to straight (0°) angled abutments. Overall, patients reported high satisfaction with the immediate restoration, as reflected by the OHIP‐14 and EQ‐5D‐5L scores. Conclusions: Immediate restoration with full‐arch implants yields excellent clinical outcomes and improves Oral Health‐Related Quality of Life (OHRQoL). While bone levels tend to stabilize after 2 years, the high incidence of prosthetic complications underscores the critical need for rigorous long‐term maintenance protocols.
- 21 January 2026
- Published by Wiley in Clinical Implant Dentistry and Related Research
- Vol. 28 (1) , e70119
A Retrospective Study of Clinical Risk Factors and Patient‐Reported Outcomes of Full‐Arch Implant‐Supported Prostheses
Objectives: This study aimed to evaluate clinical outcomes, marginal bone loss (MBL) trends, risk factors, and patient‐reported outcomes (PROs) of immediate full‐arch implant restoration to guide clinical decision‐making. Materials and Methods: A retrospective analysis was conducted on 50 patients with 256 implants who underwent immediate restoration. Clinical and imaging data, implant survival rates, and mechanical complications were analyzed. MBL was measured at five time points using cone beam computed tomography (CBCT): T0 (immediately post‐implantation), T1 (6 months), T2 (1 year), T3 (2 years), and T4 (3–5 years). PROs were assessed using the Oral Health Impact Profile‐14 (OHIP‐14) and the European Five‐Dimensional Health Inventory‐5 L (EQ‐5D‐5L). Results: The implant survival rate was 98%, with an average follow‐up of 42 ± 16.36 months. Mechanical complications occurred in 46% of cases. MBL was most rapid between T0 and T2 and slowed from T2 to T4. Significant risk factors for increased MBL included smoking, maxillary implants, female gender, and advanced age. Furthermore, 30° angled multi‐unit abutments on posterior implants were associated with greater MBL compared to straight (0°) angled abutments. Overall, patients reported high satisfaction with the immediate restoration, as reflected by the OHIP‐14 and EQ‐5D‐5L scores. Conclusions: Immediate restoration with full‐arch implants yields excellent clinical outcomes and improves Oral Health‐Related Quality of Life (OHRQoL). While bone levels tend to stabilize after 2 years, the high incidence of prosthetic complications underscores the critical need for rigorous long‐term maintenance protocols.
- Open Access
- 15 January 2024
- Published by Springer Nature in Bone Research
- Vol. 12 (1) , 1-12
MicroRNA-146a-loaded magnesium silicate nanospheres promote bone regeneration in an inflammatory microenvironment
Reconstruction of irregular oral-maxillofacial bone defects with an inflammatory microenvironment remains a challenge, as chronic local inflammation can largely impair bone healing. Here, we used magnesium silicate nanospheres (MSNs) to load microRNA-146a-5p (miR-146a) to fabricate a nanobiomaterial, MSN+miR-146a, which showed synergistic promoting effects on the osteogenic differentiation of human dental pulp stem cells (hDPSCs). In addition, miR-146a exhibited an anti-inflammatory effect on mouse bone marrow-derived macrophages (BMMs) under lipopolysaccharide (LPS) stimulation by inhibiting the NF-κB pathway via targeting tumor necrosis factor receptor-associated factor 6 (TRAF6), and MSNs could simultaneously promote M2 polarization of BMMs. MiR-146a was also found to inhibit osteoclast formation. Finally, the dual osteogenic-promoting and immunoregulatory effects of MSN+miR-146a were further validated in a stimulated infected mouse mandibular bone defect model via delivery by a photocuring hydrogel. Collectively, the MSN+miR-146a complex revealed good potential in treating inflammatory irregular oral-maxillofacial bone defects.
- 15 January 2024
- Published by Springer Nature in Bone Research
- Vol. 12 (1) , 1-12
Open AccessMicroRNA-146a-loaded magnesium silicate nanospheres promote bone regeneration in an inflammatory microenvironment
Reconstruction of irregular oral-maxillofacial bone defects with an inflammatory microenvironment remains a challenge, as chronic local inflammation can largely impair bone healing. Here, we used magnesium silicate nanospheres (MSNs) to load microRNA-146a-5p (miR-146a) to fabricate a nanobiomaterial, MSN+miR-146a, which showed synergistic promoting effects on the osteogenic differentiation of human dental pulp stem cells (hDPSCs). In addition, miR-146a exhibited an anti-inflammatory effect on mouse bone marrow-derived macrophages (BMMs) under lipopolysaccharide (LPS) stimulation by inhibiting the NF-κB pathway via targeting tumor necrosis factor receptor-associated factor 6 (TRAF6), and MSNs could simultaneously promote M2 polarization of BMMs. MiR-146a was also found to inhibit osteoclast formation. Finally, the dual osteogenic-promoting and immunoregulatory effects of MSN+miR-146a were further validated in a stimulated infected mouse mandibular bone defect model via delivery by a photocuring hydrogel. Collectively, the MSN+miR-146a complex revealed good potential in treating inflammatory irregular oral-maxillofacial bone defects.
- Open Access
- 10 October 2023
- Published by Wiley in Clinical Oral Implants Research
- Vol. 35 (1) , 31-39
Clinical accuracy of partially guided implant placement in edentulous patients: A computed tomography‐based retrospective study
This retrospective study was intended to evaluate the clinical accuracy of partially guided template in guiding implant placement in edentulous patients. A total of 120 implants were placed in 24 patients with at least one completely edentulous arch with a partially guided system. Based on CBCT data, a repeatable method was used to measure linear and angular deviations of implants at 3D level in Mimics medical software. The influence of supporting tissue and implant region on the accuracy was assessed, followed by the evaluation of direction of linear deviations in biologically vital areas. Linear deviations of all implants were 1.91 ± 0.68 mm, 1.47 ± 0.68 mm, and 1.02 ± 0.69 mm at apical, apical lateral, and apical vertical levels. When at the cervical, cervical lateral, and cervical vertical levels, the linear deviations were 1.53 ± 0.65 mm, 0.98 ± 0.53 mm, and 1.01 ± 0.69 mm, respectively. Angular deviation of all implants was 7.14 ± 3.41°. Implants guided by mucosa + tooth-supported templates showed higher linear deviations at apical vertical level (1.21 ± 0.72 mm vs. 0.86 ± 0.63 mm, p < .05) and cervical vertical level (1.18 ± 0.72 mm vs. 0.87 ± 0.63 mm, p < .05) than mucosa-supported templates, and implants in maxilla were found higher angular deviation than mandible (7.89 ± 3.61° vs. 6.29 ± 2.97°, p < .05). The partially guided template served as clinically viable surgical assistance in implant placement in edentulous patients. When using mucosa + tooth-supported template or placing implants in maxilla, more caution was required, especially in biologically vital areas.
- 10 October 2023
- Published by Wiley in Clinical Oral Implants Research
- Vol. 35 (1) , 31-39
Open AccessClinical accuracy of partially guided implant placement in edentulous patients: A computed tomography‐based retrospective study
This retrospective study was intended to evaluate the clinical accuracy of partially guided template in guiding implant placement in edentulous patients. A total of 120 implants were placed in 24 patients with at least one completely edentulous arch with a partially guided system. Based on CBCT data, a repeatable method was used to measure linear and angular deviations of implants at 3D level in Mimics medical software. The influence of supporting tissue and implant region on the accuracy was assessed, followed by the evaluation of direction of linear deviations in biologically vital areas. Linear deviations of all implants were 1.91 ± 0.68 mm, 1.47 ± 0.68 mm, and 1.02 ± 0.69 mm at apical, apical lateral, and apical vertical levels. When at the cervical, cervical lateral, and cervical vertical levels, the linear deviations were 1.53 ± 0.65 mm, 0.98 ± 0.53 mm, and 1.01 ± 0.69 mm, respectively. Angular deviation of all implants was 7.14 ± 3.41°. Implants guided by mucosa + tooth-supported templates showed higher linear deviations at apical vertical level (1.21 ± 0.72 mm vs. 0.86 ± 0.63 mm, p < .05) and cervical vertical level (1.18 ± 0.72 mm vs. 0.87 ± 0.63 mm, p < .05) than mucosa-supported templates, and implants in maxilla were found higher angular deviation than mandible (7.89 ± 3.61° vs. 6.29 ± 2.97°, p < .05). The partially guided template served as clinically viable surgical assistance in implant placement in edentulous patients. When using mucosa + tooth-supported template or placing implants in maxilla, more caution was required, especially in biologically vital areas.
- Open Access
- 8 May 2023
- Published by Springer Nature in Research Square
MicroRNA146a-loaded Magnesium Silicate Nanospheres promote bone regeneration with inflammatory microenvironment
The reconstruction of irregular oral-maxillofacial bone defects with an inflammatory microenvironment remains a clinical challenge as chronic local inflammation can largely impair bone healing. Here, we used magnesium silicate nanospheres (MSN) to load a nucleic acid drug - microRNA146a-5p (miR146a), fabricating a nanobiomaterial complex MSN-miR146a with high oligo transfection efficiency. This complex showed a potent promoting effect on osteogenic differentiation of human dental pulp stem cells with upregulated expression of osteogenesis markers including alkaline phosphatase, collagen Ⅰ, Runt-related transcription factor 2, osteopontin and Osterix. Additionally, miR146a was observed to have an anti-inflammatory effect by reducing CD40high M1 pro-inflammatory mouse bone marrow derived macrophages under lipopolysaccharide stimulation, with MSN simultaneously upregulating Arginase-1high or CD163high M2 pro-regenerative BMMs. The osteogenic-promoting and immunoregulatory effects of MSN-miR146a were further validated in a mouse-infected mandibular bone defect model delivered by photocuring hydrogel. Collectively, the MSN-miR146a complex revealed great potential in treating inflammatory irregular oral-maxillofacial bone defects.
- 8 May 2023
- Published by Springer Nature in Research Square
Open AccessMicroRNA146a-loaded Magnesium Silicate Nanospheres promote bone regeneration with inflammatory microenvironment
The reconstruction of irregular oral-maxillofacial bone defects with an inflammatory microenvironment remains a clinical challenge as chronic local inflammation can largely impair bone healing. Here, we used magnesium silicate nanospheres (MSN) to load a nucleic acid drug - microRNA146a-5p (miR146a), fabricating a nanobiomaterial complex MSN-miR146a with high oligo transfection efficiency. This complex showed a potent promoting effect on osteogenic differentiation of human dental pulp stem cells with upregulated expression of osteogenesis markers including alkaline phosphatase, collagen Ⅰ, Runt-related transcription factor 2, osteopontin and Osterix. Additionally, miR146a was observed to have an anti-inflammatory effect by reducing CD40high M1 pro-inflammatory mouse bone marrow derived macrophages under lipopolysaccharide stimulation, with MSN simultaneously upregulating Arginase-1high or CD163high M2 pro-regenerative BMMs. The osteogenic-promoting and immunoregulatory effects of MSN-miR146a were further validated in a mouse-infected mandibular bone defect model delivered by photocuring hydrogel. Collectively, the MSN-miR146a complex revealed great potential in treating inflammatory irregular oral-maxillofacial bone defects.